DNA X, Inc.
SONMNASDAQTechnology● Active
$5.06
+$0.31(+6.53%)
Market Cap$5206271
P/E Ratio—
52W High$38.52
52W Low$2.521
DNA X, Inc. (SONM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
SONM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 20, 2026EPS Actual
-$3.11
Est. $5.04 · -161.7%
Revenue
—
Est. $0.04B
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 20, 2026
After Market Close
▼ Miss EPS
SONM reports quarterly as a NASDAQ-listed Communication Equipment company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.46
Rev. $3.65B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.46
Rev. Est.$3.65B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 17, 2026 | $5.22 | — | — | — | $0.04B | — |
| ▼ Q2 FY2026 | May 20, 2026 | $5.04 | -$3.11 | -161.7% | — | $0.04B | — |
| ▼ Q1 FY2026 | Jan 30, 2026 | $10.97 | -$10.97 | -200.0% | $-0.04B | $0.04B | -207.1% |
| ▼ Q4 FY2025 | Oct 31, 2025 | $5.40 | -$3.86 | -171.5% | $0.02B | $0.03B | -52.8% |
| ▼ Q3 FY2025 | Aug 8, 2025 | $0.72 | -$10.97 | -1623.6% | $0.01B | $0.03B | -61.6% |
| ▲ Q2 FY2025 | May 12, 2025 | -$0.13 | $0.08 | +161.5% | $0.02B | $0.03B | -34.2% |
| ▼ Q2 FY2025 | Apr 2, 2025 | -$0.40 | -$4.34 | -984.2% | $0.01B | $0.02B | -23.4% |
| ▲ Q4 FY2024 | Nov 13, 2024 | -$0.66 | -$0.52 | +21.2% | $0.02B | $0.01B | +1.6% |
Q3 FY2026
Aug 17, 2026
EPS Actual
—
EPS Est.
$5.22
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 20, 2026Miss
EPS Actual
-$3.11
EPS Est.
$5.04
EPS Surpr.
-161.7%
Revenue
—
Q1 FY2026
Jan 30, 2026Miss
EPS Actual
-$10.97
EPS Est.
$10.97
EPS Surpr.
-200.0%
Revenue
$-0.04B
Q4 FY2025
Oct 31, 2025Miss
EPS Actual
-$3.86
EPS Est.
$5.40
EPS Surpr.
-171.5%
Revenue
$0.02B
Q3 FY2025
Aug 8, 2025Miss
EPS Actual
-$10.97
EPS Est.
$0.72
EPS Surpr.
-1623.6%
Revenue
$0.01B
Q2 FY2025
May 12, 2025Beat
EPS Actual
$0.08
EPS Est.
-$0.13
EPS Surpr.
+161.5%
Revenue
$0.02B
Q2 FY2025
Apr 2, 2025Miss
EPS Actual
-$4.34
EPS Est.
-$0.40
EPS Surpr.
-984.2%
Revenue
$0.01B
Q4 FY2024
Nov 13, 2024Beat
EPS Actual
-$0.52
EPS Est.
-$0.66
EPS Surpr.
+21.2%
Revenue
$0.02B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $4.86 | $4.86 | $4.86 | 1 |
| Q3 FY2026 | $5.04 | $5.04 | $5.04 | 1 |
| Q2 FY2026 | $5.22 | $5.22 | $5.22 | 1 |
| Q1 FY2026 | $5.04 | $5.04 | $5.04 | 1 |
| Q4 FY2025 | $5.40 | $5.40 | $5.40 | 1 |
| Q3 FY2025 | $0.72 | $0.72 | $0.72 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2025 | $0.0B | $0.0B | $0.0B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 20, 2026 | -161.7% | $4.30 | $4.48 | +4.19% |
| ▼ Q1 FY2026 | Jan 30, 2026 | -200.0% | $6.25 | $5.64 | -9.76% |
| ▼ Q4 FY2025 | Oct 31, 2025 | -171.5% | $11.12 | $11.61 | +4.41% |
| ▼ Q3 FY2025 | Aug 8, 2025 | -1623.6% | $10.98 | $10.98 | +0.00% |
| ▲ Q2 FY2025 | May 12, 2025 | +161.5% | $25.02 | $26.82 | +7.19% |
| ▼ Q2 FY2025 | Apr 2, 2025 | -984.2% | $53.28 | $57.60 | +8.11% |
| ▲ Q4 FY2024 | Nov 13, 2024 | +21.2% | $63.72 | $59.58 | -6.50% |
| ▲ Q3 FY2024 | Aug 9, 2024 | +0.0% | $52.20 | $53.10 | +1.72% |
Q2 FY2026+4.19%
Report Date
May 20, 2026
EPS Beat/Miss
-161.7%
Price Before
$4.30
Price After
$4.48
Q1 FY2026-9.76%
Report Date
Jan 30, 2026
EPS Beat/Miss
-200.0%
Price Before
$6.25
Price After
$5.64
Q4 FY2025+4.41%
Report Date
Oct 31, 2025
EPS Beat/Miss
-171.5%
Price Before
$11.12
Price After
$11.61
Q3 FY2025+0.00%
Report Date
Aug 8, 2025
EPS Beat/Miss
-1623.6%
Price Before
$10.98
Price After
$10.98
Q2 FY2025+7.19%
Report Date
May 12, 2025
EPS Beat/Miss
+161.5%
Price Before
$25.02
Price After
$26.82
Q2 FY2025+8.11%
Report Date
Apr 2, 2025
EPS Beat/Miss
-984.2%
Price Before
$53.28
Price After
$57.60
Q4 FY2024-6.50%
Report Date
Nov 13, 2024
EPS Beat/Miss
+21.2%
Price Before
$63.72
Price After
$59.58
Q3 FY2024+1.72%
Report Date
Aug 9, 2024
EPS Beat/Miss
+0.0%
Price Before
$52.20
Price After
$53.10
Avg Beat Reaction+0.80%
Avg Miss Reaction+1.39%
Beat Rate3 / 8 quarters
Largest Move-9.76% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: SONM ends December
DNA X, Inc. (SONM) most recently reported earnings on May 20, 2026 for Q2 FY2026, posting EPS of $-3.11 — missing the analyst consensus of $5.04 by -161.7%. The next SONM earnings date is expected around September 1, 2026.
Each quarter, investors track SONM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. SONM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
SONM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
SONM earnings · 5 questionsDNA X, Inc.'s next earnings report is expected around September 1, 2026. SONM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; SONM historically reports after market close (AMC).
SONM earnings datewhen is SONM earningsSONM next earnings datewhen does SONM report earningsSONM earnings calendar
▸ Source: FMP · DNA X, Inc. SEC filings · US GAAP · DNA X, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026